feed,title,long_url,short_url
BioRxiv,SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules,https://biorxiv.org/cgi/content/short/2023.04.07.536037v1?rss=1,https://da.gd/lVLpyA
